Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington’s disease for participants of varying functional disability: a pilot study
Abstract Huntington’s Disease (HD) is a progressive, fatal neurodegenerative condition. While generally considered for its devastating neurological phenotype, disturbances in other organ systems and metabolic pathways outside the brain have attracted attention for possible relevance to HD pathology,...
Main Authors: | Andrew McGarry, John Gaughan, Cory Hackmyer, Jacqueline Lovett, Mohammed Khadeer, Hamza Shaikh, Basant Pradhan, Thomas N. Ferraro, Irving W. Wainer, Ruin Moaddel |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-77526-9 |
Similar Items
-
Author Correction: Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington’s disease for participants of varying functional disability: a pilot study
by: Andrew McGarry, et al.
Published: (2021-05-01) -
Ketamine Metabolites Enantioselectively Decrease Intracellular D-Serine Concentrations in PC-12 Cells.
by: Nagendra S Singh, et al.
Published: (2016-01-01) -
Editorial of Special Column “Natural Product Screening”
by: Ruin Moaddel, et al.
Published: (2020-10-01) -
EPA and Huntington's chorea: treatment and associated cerebral changes
by: Puri Basant K
Published: (2010-04-01) -
Comparative transcriptomics of choroid plexus in Alzheimer’s disease, frontotemporal dementia and Huntington’s disease: implications for CSF homeostasis
by: Edward G. Stopa, et al.
Published: (2018-05-01)